2020 ASCO Virtual Direct™ Highlights
Playback speed
10 seconds
2020 ASCO Update on Melanoma: Is There Significant Antitumor Activity for Low-dose Ipilimumab + Pembrolizumab Immediately Following Progression on PD-1 Ab in Melanoma?
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
William Sharfman
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
William Sharfman
0 views
July 17, 2020
Comments 0
Login to view comments.
Click here to Login
Skin